🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Comparison of 2 doses of empagliflozin vs placebo in patients already using...
Status
Completed
Location
AMCR Institute, Inc.
Start Date
2015-06-30
Trial ID
NCT02414958
Treatments Being Tested
Heart Failure (HF) in Australia affects 1-2% of the population. Heart failu...
Status
Terminated
Location
Royal Prince Alfred Hospital
Start Date
2022-10-01
Trial ID
NCT05129722
Treatments Being Tested
The aim of this study is to investigate the efficacy and safety of two dose...
Status
Completed
Location
1276.10.11036 Boehringer Ingelheim Investigational Site
Start Date
2012-10
Trial ID
NCT01649297
Investigation of food effect on the bioavailability of a 25 mg empagliflozi...
Status
Completed
Location
1245.79.1 Boehringer Ingelheim Investigational Site
Start Date
2011-10
Trial ID
NCT01451775
Treatments Being Tested
Primary objective:To investigate if BI 10773 affects the pharmacokinetics o...
Status
Completed
Location
1245.45.1 Boehringer Ingelheim Investigational Site
Start Date
2011-01
Trial ID
NCT01284621
This study will investigate the efficacy and safety of BI 10773 in type 2 d...
Status
Completed
Location
1245.19.10056 Boehringer Ingelheim Investigational Site
Start Date
2010-09
Trial ID
NCT01210001
This trial is designed to investigate the efficacy and safety of empagliflo...
Status
Completed
Location
University of Alabama at Birmingham
Start Date
2014-07-25
Trial ID
NCT02182830
Treatments Being Tested
The objective of this study is to demonstrate that BI 10773 does not prolon...
Status
Completed
Location
1245.16.1 Boehringer Ingelheim Investigational Site
Start Date
2010-08
Trial ID
NCT01195675
Treatments Being Tested
The primary objective of this exploratory meta-analysis is to evaluate the ...
Status
Completed
Location
Boehringer Ingelheim
Start Date
2021-06-01
Trial ID
NCT04937816
Treatments Being Tested
This is a randomized, open label, adaptive platform trial to compare the ef...
Status
Completed
Location
University of Alabama
Start Date
2020-09-04
Trial ID
NCT04505774
Treatments Being Tested